4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000012
Options or other derivatives
- President and CEO acquired 398,018 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Parikh Anand Kiran · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-21 | Grant or award : show line 1 in the form Performance-Based Stock Option (right to buy) | +398,018 | 398,018 | D |
Loading xslF345X06/form4-07232026_040701.xml…